| The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK N Frey, J Jossi, M Bodmer, A Bircher, SS Jick, CR Meier, J Spoendlin Journal of Investigative Dermatology 137 (6), 1240-1247, 2017 | 192 | 2017 |
| The risk of Stevens‐Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs N Frey, M Bodmer, A Bircher, S Rüegg, SS Jick, CR Meier, J Spoendlin Epilepsia 58 (12), 2178-2185, 2017 | 75 | 2017 |
| Hyperlipidaemia and incident osteoarthritis of the hand: a population-based case-control study N Frey, T Hügle, SS Jick, CR Meier, J Spoendlin Osteoarthritis and cartilage 25 (7), 1040-1045, 2017 | 56 | 2017 |
| Type II diabetes mellitus and incident osteoarthritis of the hand: a population-based case–control analysis N Frey, T Hügle, SS Jick, CR Meier, J Spoendlin Osteoarthritis and cartilage 24 (9), 1535-1540, 2016 | 55 | 2016 |
| Stevens–Johnson syndrome and toxic epidermal necrolysis in association with commonly prescribed drugs in outpatient care other than anti-epileptic drugs and antibiotics: A … N Frey, M Bodmer, A Bircher, SS Jick, CR Meier, J Spoendlin Drug safety 42, 55-66, 2019 | 40 | 2019 |
| Antibiotic drug use and the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based case-control study N Frey, A Bircher, M Bodmer, SS Jick, CR Meier, J Spoendlin The Journal of investigative dermatology 138 (5), 1207-1209, 2018 | 22 | 2018 |
| Risk of incident osteoarthritis of the hand in statin initiators: a sequential cohort study T Burkard, T Hügle, JB Layton, RJ Glynn, M Bloechliger, N Frey, SS Jick, ... Arthritis care & research 70 (12), 1795-1805, 2018 | 15 | 2018 |
| Validation of Stevens–Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink N Frey, A Bircher, M Bodmer, SS Jick, CR Meier, J Spoendlin Pharmacoepidemiology and drug safety 26 (4), 429-436, 2017 | 15 | 2017 |
| Survival after Stevens‒Johnson Syndrome or Toxic Epidermal Necrolysis: A United Kingdom‒Based Cohort Study CA Marxer, N Frey, M Bodmer, AJ Bircher, SS Jick, CR Meier, J Spoendlin The Journal of investigative dermatology 141 (5), 1349-1351. e1, 2021 | 6 | 2021 |
| Response: The risk of Stevens‐Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs: Comment on data sparsity N Frey, M Bodmer, A Bircher, S Rüegg, SS Jick, CR Meier, J Spoendlin Epilepsia 59 (5), 1084-1085, 2018 | 3 | 2018 |
| A study on the epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis N Frey University_of_Basel, 2018 | 1 | 2018 |
| Survival after Stevens-Johnson syndrome: a UK-based cohort study C Marxer, N Frey, M Bodmer, A Bircher, SS Jick, CR Meier, J Spoendlin PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 429-429, 2019 | | 2019 |
| Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Population-Based Case-Control Study NC Frey, M Bodmer, A Bircher, SS Jick, CR Meier, J Spoendlin PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 25, 604-604, 2016 | | 2016 |
| Validation of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Diagnoses in the Clinical Practice Research Datalink NC Frey, A Bircher, M Bodmer, SS Jick, CR Meier, J Spoendlin PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 25, 162-163, 2016 | | 2016 |
| Type II Diabetes Mellitus, Antidiabetic Drugs, and Statins and the Risk of Developing Osteoarthritis in Non-weight Bearing Joints N Frey, J Spoendlin, T Huegle, SS Jick, CR Meier PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 24, 324-325, 2015 | | 2015 |
| 2.3 Types of Cutaneous ADR N Frey, J Spoendlin Cutaneous Drug Hypersensitivity, 14, 0 | | |
